Adverum Biotechnologies, Inc. (ADVM) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Zygtech, LLC mit 2,442,776 Aktien. Weitere bedeutende Anteilseigner sind Salzman Amber und Chalberg Thomas W..
In den letzten 12 Monaten haben Insider 21 Transaktionen in ADVM Aktien getätigt — 12 Käufe (im Wert von $1.34M) und 3 Verkäufe (im Wert von $26.02K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
ADVM Insider-Beteiligungen
Größter Aktionär
Zygtech, LLC
2,442,776 Aktien
Käufe (12 Monate)
12
$1.34M Wert
Verkäufe (12 Monate)
3
$26.02K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Zygtech, Llc |
10 Percent Owner |
2,442,776 |
2015-04-15 |
|
| 2 |
Salzman Amber |
President and CEO |
478,000 |
2018-02-20 |
|
| 3 |
Chalberg Thomas W. |
Chief Executive Officer |
258,988 |
2015-06-11 |
|
| 4 |
Rakow John |
SVP, Genl Counsel, Acting CFO |
250,000 |
2022-06-10 |
|
| 5 |
Patterson Leone D |
President and CFO |
240,000 |
2021-02-18 |
|
| 6 |
Beckman Richard |
Chief Medical Officer |
225,000 |
2023-03-03 |
|
| 7 |
Clark Julie |
Chief Medical Officer |
164,723 |
2021-10-04 |
|
| 8 |
Braun Shirley |
VP, Human Resources |
161,140 |
2016-02-17 |
|
| 9 |
Countouriotis Athena |
SVP, Chief Medical Officer |
160,000 |
2018-02-20 |
|
| 10 |
Osborne Aaron |
Chief Medical Officer |
150,000 |
2021-02-18 |
|
| 11 |
Leonard Braden Michael |
10 Percent Owner |
141,800 |
2025-04-28 |
|
| 12 |
Hull Hans |
Chief Executive Officer |
137,210 |
2015-08-25 |
|
| 13 |
Leung Thomas |
Chief Financial Officer |
120,000 |
2020-02-21 |
|
| 14 |
Thedinga Angela |
Chief Technology Officer |
120,000 |
2021-08-10 |
|
| 15 |
Riley Brigit |
Chief Scientific Officer |
117,435 |
2023-03-17 |
|
| 16 |
Fischer Laurent |
CEO, President and Director |
87,488 |
2025-05-16 |
|
| 17 |
Barone Samuel B. |
SVP, Clinical Development |
84,000 |
2017-02-13 |
|
| 18 |
Swartzburg Michael |
Principal Accounting Officer |
82,113 |
2016-02-17 |
|
| 19 |
Cheng Jennifer C. |
General Counsel |
80,000 |
2019-02-19 |
|
| 20 |
Rubio Roman G. |
SVP, Translational Medicine |
75,000 |
2016-02-17 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2025-06-17 |
Kiss Szilard |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Hong Soo |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Seyedkazemi Setareh |
Chief Development Officer |
Aktienrückgabe |
8,500 |
$12.90 |
$109.65K |
| 2025-06-10 |
Seyedkazemi Setareh |
Chief Development Officer |
Aktienrückgabe |
40,000 |
$19.90 |
$796K |
| 2025-06-17 |
Ozden Rabia Gurses |
Chief Medical Officer |
Aktienrückgabe |
8,000 |
$13.50 |
$108K |
| 2025-06-17 |
Lupher, Jr. Mark L. |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Soparkar Peter |
Chief Operating Officer |
Aktienrückgabe |
40,000 |
$68.80 |
$2.75M |
| 2025-06-17 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Svoronos Dawn |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Tuckson Reed Vaughn |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Fischer Laurent |
CEO, President and Director |
Aktienrückgabe |
68,000 |
$134.40 |
$9.14M |
| 2025-06-17 |
Scopa James Paul |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-06-17 |
Rubinstein Linda M |
Chief Financial Officer |
Aktienrückgabe |
35,000 |
$19.90 |
$696.5K |
| 2025-06-17 |
Machado Patrick |
Director |
RSU-Zuteilung |
3,140 |
$2.32 |
$7.28K |
| 2025-06-17 |
Whitcup Scott M |
Director |
RSU-Zuteilung |
10,450 |
$2.32 |
$24.24K |
| 2025-05-15 |
Seyedkazemi Setareh |
Chief Development Officer |
Informierter Verkauf |
924 |
$2.00 |
$1.85K |
| 2025-05-15 |
Soparkar Peter |
Chief Operating Officer |
Informierter Verkauf |
2,960 |
$2.00 |
$5.92K |
| 2025-05-15 |
Fischer Laurent |
CEO, President and Director |
Informierter Verkauf |
9,126 |
$2.00 |
$18.25K |
| 2025-03-27 |
Leonard Braden Michael |
10 Percent Owner |
Informierter Kauf |
16,593 |
$5.19 |
$86.09K |
| 2025-04-23 |
Leonard Braden Michael |
10 Percent Owner |
Informierter Kauf |
50,000 |
$2.98 |
$148.95K |
| 2025-04-22 |
Leonard Braden Michael |
10 Percent Owner |
Informierter Kauf |
300,000 |
$3.00 |
$900K |
